- €212.86m
- €410.22m
- €480.36m
- 87
- 52
- 30
- 58
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 686 | 782 | 764 | 404 | 480 |
Cost of Revenue | |||||
Gross Profit | 110 | 131 | 145 | 57 | 85.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 667 | 745 | 723 | 384 | 447 |
Operating Profit | 18.3 | 37.8 | 40.6 | 19.8 | 33.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 12.7 | 30 | 31.9 | 20.1 | 28.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.36 | 18.5 | 12.5 | 12.4 | 20.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 5.86 | 15.1 | -0.356 | 11.8 | 21.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 5.9 | 15.1 | -0.356 | 11.8 | 21.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.496 | 1.44 | 1.14 | 1.11 | 1.5 |
Dividends per Share |